Metaraminol 10mg/ml Solution for Injection or Infusion

국가: 영국

언어: 영어

출처: myHealthbox

유효 성분:

metaraminol

제공처:

South Devon Healthcare NHS Foundation Trust

ATC 코드:

C01CA09

INN (International Name):

metaraminol

복용량:

10mg/ml

약제 형태:

Solution for injection or infusion

관리 경로:

Intravenous use

패키지 단위:

Pack size of 10 ampoules in an outer carton

처방전 유형:

POM - Prescription Only Medicine

Manufactured by:

South Devon Healthcare NHS Foundation Trust

치료 그룹:

Adrenergic and dopaminergic agent

치료 징후:

For the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and as an adjunct to accepted remedial procedures.

승인 상태:

Authorised

승인 날짜:

2015-07-06

환자 정보 전단

제품 특성 요약

Metaraminol 10mg/mL Solution for Injection or Infusion
Summary of Product Characteristics Updated 14­Sep­2015 | Torbay Pharmaceuticals, South Devon Healthcare NHS
Foundation Trust
1. Name of the medicinal product
Metaraminol 10mg/mL Solution for Injection or Infusion.
2. Qualitative and quantitative composition
Each 1 mL of solution contains 10mg of metaraminol (as tartrate).
Excipients of known effect:
Sodium chloride
Sodium metabisulfite
Each 1 mL of solution contains 98.4 mmol (2.26 mg) sodium.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for injection or infusion.
Glass ampoule containing a clear colourless solution with pH of 3.2 to 4.5 and osmolarity of 305mOsm/litre.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and
as an adjunct to accepted remedial procedures.
4.2 Posology and method of administration
_Method of Administration_
For intravenous use.
_Posology_
_Direct intravenous injection in grave emergencies: _0.5 ­5 mg (0.05­0.5 ml), followed by an infusion of 15­100 mg (1.5­10
ml) in 500 ml of infusion liquid.
Particular care should be taken to use the correct dose when injecting undiluted metaraminol.
_Intravenous Infusion:_ 15­100 mg (1.5­10.0 ml) in 500 ml Sodium Chloride Injection or Dextrose 5% Injection, adjusting
the rate of infusion to maintain the blood pressure at the desired level. Higher concentrations of Metaraminol have been
used when appropriate to the circumstances.
_Children:_ Metaraminol should not be used in children under 12 years of age.
_Use in the elderly: _The dosage may not require modification for elderly patients; however, geriatric patients may be
more sensitive to sympathomimetic�